NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Antonio Pérez Martínez, MD, PhD.
aperezmartinez@salud.madrid.org
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitario de Cruces
Barakaldo, Vizcaya, Spain
- Hospital Materno Infantil de Badajoz
Badajoz, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario la Paz
Madrid, Spain
- Hospital de la Arrixaca
Murcia, Spain
- Hospital Materno-Infantil de Málaga
Málaga, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2016
- Primary completion
- 31 Aug 2020
- Completion
- 31 Aug 2020
- Last update posted
- 5 Oct 2020
- Registered enrollment
- 7
- Registry id
- NCT02763475
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.